GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (HKSE:02616) » Definitions » PB Ratio

CStone Pharmaceuticals (HKSE:02616) PB Ratio : 9.84 (As of Apr. 24, 2025)


View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-24), CStone Pharmaceuticals's share price is HK$3.00. CStone Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2024 was HK$0.31. Hence, CStone Pharmaceuticals's PB Ratio of today is 9.84.

Warning Sign:

CStone Pharmaceuticals stock PB Ratio (=9.51) is close to 2-year high of 9.51.

The historical rank and industry rank for CStone Pharmaceuticals's PB Ratio or its related term are showing as below:

HKSE:02616' s PB Ratio Range Over the Past 10 Years
Min: 2.17   Med: 4.31   Max: 12.94
Current: 9.68

During the past 9 years, CStone Pharmaceuticals's highest PB Ratio was 12.94. The lowest was 2.17. And the median was 4.31.

HKSE:02616's PB Ratio is ranked worse than
89.34% of 1285 companies
in the Biotechnology industry
Industry Median: 2.18 vs HKSE:02616: 9.68

During the past 3 years, the average Book Value Per Share Growth Rate was -49.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -21.90% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of CStone Pharmaceuticals was 79.80% per year. The lowest was -49.20% per year. And the median was 27.90% per year.

Back to Basics: PB Ratio


CStone Pharmaceuticals PB Ratio Historical Data

The historical data trend for CStone Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals PB Ratio Chart

CStone Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only 3.39 6.64 11.05 5.79 7.54

CStone Pharmaceuticals Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.05 - 5.79 2.89 7.54

Competitive Comparison of CStone Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, CStone Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CStone Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's PB Ratio falls into.


;
;

CStone Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

CStone Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=3.00/0.305
=9.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


CStone Pharmaceuticals  (HKSE:02616) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


CStone Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CStone Pharmaceuticals Business Description

Traded in Other Exchanges
Address
218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Suzhou, CHN, 215123
CStone Pharmaceuticals is engaged in the development and commercialization of tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.
Executives
Pfizer Inc. 2201 Interest of corporation controlled by you
Yang Jianxin 2101 Beneficial owner
Boyu Capital Fund Ii, L.p. 2201 Interest of corporation controlled by you
Boyu Capital General Partner Ii, L.p. 2201 Interest of corporation controlled by you
Boyu Capital General Partner Ii, Ltd. 2201 Interest of corporation controlled by you
Boyu Capital Holdings Ltd. 2201 Interest of corporation controlled by you
Graceful Beauty Limited 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Jian Kang Chuang Ye Tou Zi Guan Li Zhong Xin You Xian He Huo 2501 Other
Su Zhou Gong Ye Yuan Qu Yuan He Yuan Dian Chuang Ye Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Guan Wei Hui 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Jing Ji Fa Zhan You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Yuan He Kong Gu Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Ji Ming Gu Quan Tou Zi Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Su Zhou Gong Ye Yuan Qu Zheng Ze Yuan Shi Chuang Ye Tou Zi Qi Ye You Xian He Huo 2101 Beneficial owner

CStone Pharmaceuticals Headlines

No Headlines